![]() |
|
|
1 Laboratory of Chemical Pharmacology, National Heart Institute, National Institutes of Health, United States Public Health Service, Bethesda, Maryland
Methods for the estimation of ephedrine and its metabolic products, norephedrine, p-hydroxynorephedrine and p-hydroxyephedrine, in biological materials, are described.
In the dog the main route of biotransformation of ephedrine involves demethylation to norephedrine. The rate of demethylation is rapid, indicating that the activity of ephedrine is mediated largely through norephedrine. Norephedrine is excreted in the urine mainly unchanged. A minor route of metabolism of ephedrine involves hydroxylation of the aromatic nucleus to form p-hydroxyephedrine and p-hydroxynorephedrine, which are excreted partly free and partly as conjugates. Both ephedrine and norephedrine are highly localized in various organ tissues. Demethylation to norephedrine is a major route of metabolism in the dog and guinea pig and a minor pathway in the rat. On the other hand, hydroxylation of the drug constitutes a minor pathway of metabolism in the dog and guinea pig but a major one in the rat.
Submitted on April 3, 1953
This article has been cited by other articles:
![]() |
R. P. Rubin A Brief History of Great Discoveries in Pharmacology: In Celebration of the Centennial Anniversary of the Founding of the American Society of Pharmacology and Experimental Therapeutics Pharmacol. Rev., December 1, 2007; 59(4): 289 - 359. [Full Text] [PDF] |
||||
![]() |
J. Axelrod Journey of a Late Blooming Biochemical Neuroscientist J. Biol. Chem., January 3, 2003; 278(1): 1 - 13. [Full Text] [PDF] |
||||